Develops engineered B cell medicines and protein-based therapies to treat serious diseases, focusing on innovative therapeutic solutions.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Be Biopharma focuses on advancing therapeutic solutions using engineered B cell medicines to treat serious diseases. Their approach aims to transform care, particularly for conditions like hemophilia B, by reimagining protein-based therapies. The company integrates cutting-edge science with a patient-centered mission to drive innovation in the field.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Be Biopharma Management Team
Be Biopharma Valuations & Financials
View real-time NPM data on Be Biopharma stock including daily Be Biopharma stock price estimates, valuation history, and historical share price information. Access Be Biopharma financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Be Biopharma pricing across six independent market signals. Looking for private company due diligence data sources on Be Biopharma? Get in touch to learn more.
Similar Companies
like Be Biopharma
ViuHealth
Healthcare & Life Sciences
Enables remote autoimmune management by tracking symptoms, offering lifestyle support, and facilitating continuous coach-led guidance.
Circular Genomics
Healthcare & Life Sciences
Decodes circular RNAs into biomarkers which guide diagnosis and therapy in brain disorders.
Brave Health
Healthcare & Life Sciences
Digital healthcare platform delivering virtual mental health therapy and support services through an accessible online interface.
LimiFlex
Healthcare & Life Sciences
Offering a dynamic spinal tether that stabilizes vertebrae during flexion while preserving natural movement after decompression surgery.
Pendulum
Healthcare & Life Sciences
A biotechnology company that provides microbiome-targeted medical probiotics designed to improve health outcomes.
64x Bio
Healthcare & Life Sciences
Develop scalable cell platforms that enhance therapy manufacturing by optimizing production efficiency.
Arya For Work
Healthcare & Life Sciences
Empowers healthcare providers with AI agents that streamline staffing, pay, onboarding, and compliance for seamless operations.
Doro Mind
Healthcare & Life Sciences
Offers tailored mental health care and support services for individuals and families navigating serious mental illness.
Peptilogics
Healthcare & Life Sciences
Leverages artificial intelligence to design and develop peptide-based therapeutic drugs for treating serious diseases.
FAQ
We have answers
Be Biopharma stock does not trade on public stock exchanges. Be Biopharma stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Be Biopharma stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Be Biopharma Stock does not trade on public stock exchanges. In order to sell Be Biopharma shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Be Biopharma does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Be Biopharma share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Be Biopharma stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Be Biopharma stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Be Biopharma stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Be Biopharma is a private company and has not had an IPO. There is currently no Be Biopharma IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Be Biopharma IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
